- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03071029
PAFP Provider Feedback Trial in Nepal
May 5, 2017 updated by: Kathryn Church, Marie Stopes International
Applying Behavioural Insights to Improve Take up of Post-abortion Family Planning: In-depth Study in Nepal
A six-month RCT conducted within 36 health centres throughout urban and rural Nepal.
The purpose of the RCT is to test the effectiveness of a peer comparison intervention at increasing uptake of long-acting reversible contraceptives (LARCs) as a percentage of PAFP uptake among clients who receive a safe abortion at a Marie Stopes International Nepal.
The total sample size will be ~12,000 safe abortion clients.
The primary outcome of interest is LARCs among safe abortion clients at Marie Stopes Centres in Nepal.
The secondary outcome is to evaluate the impact of behaviorally designed intervention on the service providers' engagement in discussing measures to increase PAFP LARC uptake among women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The overall goal of the proposed research project is to increase uptake of long-acting reversible contraceptives (LARCs) among clients who receive a safe abortion at a Marie Stopes International - Nepal (MSI-N)/ Sunaulo Parivar Nepal (SPN) centre using a behaviourally-informed intervention: monthly feedback to service providers comparing their LARC uptake as a percentage of PAFP uptake performance to other centres.
The impact of the intervention will be evaluated using a clustered, stepped wedge randomized controlled trial (RCT).
The intervention will be implemented and data will be collected regularly from 36 centres over a period of 6 months.
The RCT study design is stepped wedge, meaning that all health centres will begin in the control group and will be randomly assigned to begin receiving the treatment in 4 "steps".
Each step will be 1 month in duration.
The primary outcome of interest is LARC uptake as a percentage of PAFP uptake.
The secondary outcome is type of method selected.
The intervention consists of a monthly poster that centres will receive which shows service providers the PAFP LARC % performance at their centre as compared to 3 similar centres.
The intervention was developed using a behavioral science methodology, including interviews with clients and service providers at 9 health centres and user-testing of the intervention with service providers at 4 health centres.
Data used for this study will consist of daily PAFP LARC uptake data that is already being collected and consolidated at centres.
The data will be securely shared between centres and the MSI-N central support office in Kathmandu on a weekly basis.
Data will be securely shared between MSI-N and ideas monthly.
Monitoring will consist of mystery client visits at each centre two times during the study period.
At least one interview will be conducted with each service provider through the study period.
The investigators will manually check 5% of all medical records to confirm that electronic data is accurate.
Service providers will undergo written consent in order that they may choose to participate, or choose not to participate, in the study.
Individual clients will be opted in to having their data shared for the purpose of the study.
Clients will be notified about data sharing through posters and interactions with service providers and can choose not to have their data shared.
All safe abortion clients, aged 18 and older, are eligible to have their data shared.
Data from approximately 12,000 safe abortion clients will be required for the study.
Strict confidentiality procedures in line with Marie Stopes International's best practices will be put into place to ensure that information made public or otherwise distributed outside the PIs and other key personnel cannot be linked to any individual client records.
Results from the study will be published in a report, among other outputs, and the outcomes will be shared within MSI as well as with the wider sexual and reproductive health (SRH) community.
Study Type
Interventional
Enrollment (Actual)
12000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bagati
-
Kathmandu, Bagati, Nepal
- Marie Stopes Chuchchepati
-
Kathmandu, Bagati, Nepal
- Marie Stopes Gongabu
-
-
Bagmati
-
Kathmandu, Bagmati, Nepal
- Marie Stopes Putalisadak
-
Kathmandu, Bagmati, Nepal
- Marie Stopes Satdobato
-
Kavre, Bagmati, Nepal
- Marie Stopes Banepa
-
Nuwakot, Bagmati, Nepal
- Marie Stopes Nuwakot
-
-
Bheri
-
Banke, Bheri, Nepal
- Marie Stopes Kohalpur
-
Surkhet, Bheri, Nepal
- Marie Stopes Surkhet
-
-
Dhaulagiri
-
Parbat, Dhaulagiri, Nepal
- Marie Stopes Parbat
-
-
Gandaki
-
Gorkha, Gandaki, Nepal
- Marie Stopes Gorkha
-
Kaski, Gandaki, Nepal
- Marie Stopes Pokhara
-
Tanahun, Gandaki, Nepal
- Marie Stopes Dumre
-
-
Janakpur
-
Dhanusa, Janakpur, Nepal
- Marie Stopes Janakpur
-
Mahottari, Janakpur, Nepal
- Marie Stopes Bardibas
-
Sarlahi, Janakpur, Nepal
- Marie Stopes Lalbandi
-
-
Karnali
-
Jumla, Karnali, Nepal
- Marie Stopes Jumla
-
-
Koshi
-
Dhankuta, Koshi, Nepal
- Marie Stopes Hile
-
Morang, Koshi, Nepal
- Marie Stopes Biratnagar
-
Sunsari, Koshi, Nepal
- Marie Stopes Itahari
-
-
Lumbini
-
Arghakhachi, Lumbini, Nepal
- Marie stopes Arghakhachi
-
Gulmi, Lumbini, Nepal
- Marie Stopes Gulmi
-
Kapilbastu, Lumbini, Nepal
- Marie Stopes Chandrauta
-
Kapilbastu, Lumbini, Nepal
- Marie Stopes Taulihawa
-
Nawalparasi, Lumbini, Nepal
- Marie Stopes Bardghat
-
Rupandehi, Lumbini, Nepal
- Marie Stopes Bhairahawa
-
Rupandehi, Lumbini, Nepal
- Marie Stopes Butwal
-
-
Mahakali
-
Dadheldhura, Mahakali, Nepal
- Marie Stopes Dadheldhura
-
-
Mechi
-
Ilam, Mechi, Nepal
- Marie Stopes Ilam
-
Jhapa, Mechi, Nepal
- Marie Stopes Birtamod
-
-
Narayani
-
Chitwan, Narayani, Nepal
- Marie Stopes Narayanghat
-
Makwanpur, Narayani, Nepal
- Marie Stopes Hetauda
-
Parsa, Narayani, Nepal
- Marie Stopes Birgunj
-
-
Rapti
-
Dang, Rapti, Nepal
- Marie Stopes Dang
-
Pyuthan, Rapti, Nepal
- Marie Stopes Pyuthan
-
-
Sagarmatha
-
Siraha, Sagarmatha, Nepal
- Marie Stopes Lahan
-
-
Seti
-
Kailali, Seti, Nepal
- Marie Stopes Attariya clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- All women over the age of 18 who receive safe abortion services at the 36 centres are eligible to participate in the study. Women will be opted in to the study.
Exclusion Criteria:
- Women <18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention (receive data updates)
Intervention clinics will receive a monthly poster that centres will receive which informs service providers of the PAFP LARC uptake rate at their centre.
This is a step-wedged randomised controlled trial where all the clinics will eventually receive an intervention by the end of the study.
|
Providers will receive visual and text feedback on their centre's PAFP uptake rates as they compare to the uptake rates of other centres.
The feedback will be delivered monthly in a physical paper format.
|
No Intervention: Control (no data updates)
Service providers at these clinics will not receive monthly information on PAFP LARC rates.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long term reversible contraceptives uptake as a percentage of post-abortion family planning uptake among safe abortion clients within 2 weeks
Time Frame: 2 weeks post-abortion
|
The study aims to observe a minimum 4% difference in PAFP LARC rates at two weeks post-abortion between intervention and control participants.
|
2 weeks post-abortion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Types of family planning method used after safe abortion procedure
Time Frame: 2 weeks post abortion
|
% of participants using different types of family planning methods at two weeks post-abortion, including % using short-acting vs long-acting contraceptives.
|
2 weeks post abortion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Saugato Datta, Ideas42
- Principal Investigator: Karina Lorenzana, Ideas42
- Principal Investigator: Pragya Gartoulla, PhD, Marie Stopes Nepal
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
March 1, 2017
First Submitted That Met QC Criteria
March 3, 2017
First Posted (Actual)
March 6, 2017
Study Record Updates
Last Update Posted (Actual)
May 9, 2017
Last Update Submitted That Met QC Criteria
May 5, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 001-16
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Behavior
-
Holbaek SygehusRecruitingHealth Behavior | Health Knowledge, Attitudes, Practice | Health-Related Behavior | Health LiteracyDenmark
-
Finnish Institute for Health and WelfareCompletedHealth Behavior | Health Care Utilization | Health Care Seeking BehaviorFinland
-
University Hospital, Basel, SwitzerlandSolidarMed LesothoRecruitingRecruitment | Health Behavior | Motivation | Social Behavior | Health Care Utilization | Consumer Behavior | Health Care Seeking Behavior | Researcher-Subject RelationsLesotho
-
Basque Health ServiceUnknownHealth Promotion | Health Behavior | Health Education | Patient Education | Counseling | Behavior TherapySpain
-
Imperial College LondonRecruitingHealth Attitude | Disease | Cancer | Health Behavior | Health Knowledge, Attitudes, Practice | Health-Related BehaviorUnited Kingdom
-
Research on Healthcare Performance Lab U1290RecruitingStress | Health Behavior | Health-Related BehaviorFrance
-
Inonu UniversityEnrolling by invitationHealth Behavior | Physical Inactivity | Behavior, HealthTurkey
-
Azienda Sanitaria Locale CN2 Alba-BraUniversity of Turin, Italy; University of Eastern Piedmont; Eclectica Sas di...CompletedEffectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2) (DDS-2)Mental Health Wellness 1 | Health Behavior | Adolescent BehaviorItaly
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical... and other collaboratorsRecruitingHealth-Related Behavior | Adolescent Behavior | Adolescent Development | Health Care Seeking BehaviorGhana, Tanzania, Zimbabwe